$2.83
At close: Jun 20 EDT
$2.80
-0.03-1.06%
Pre-Market: 4:07 AM EDT
Comments
Loading...
Rocket Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RCKT | Benzinga
Rocket Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 4
EPS Estimate
$-0.530
Quarterly Revenue Estimate
$4.36M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Rocket Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals | -$0.74 | -$0.53 | — | — | $0.00 | $4.36M | — | — | 08/04/2025 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.66 | -$0.58 | -$0.56 | 3.45% | $0.00 | $800.00K | $0.00 | -100.00% | 05/08/2025 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.64 | -$0.72 | -$0.62 | 13.89% | $0.00 | $31.30K | $0.00 | -100.00% | 02/27/2025 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.75 | -$0.76 | -$0.71 | 6.58% | $0.00 | $700.00K | $0.00 | -100.00% | 11/07/2024 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.82 | -$0.72 | -$0.74 | -2.78% | $0.00 | — | $0.00 | — | 08/05/2024 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.73 | -$0.69 | -$0.66 | 4.35% | $0.00 | — | $0.00 | — | 05/06/2024 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.92 | -$0.79 | -$0.64 | 18.99% | $0.00 | — | $0.00 | — | 02/26/2024 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.87 | -$0.81 | -$0.75 | 7.41% | $0.00 | — | $0.00 | — | 11/06/2023 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.83 | -$0.79 | -$0.82 | -3.80% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.67 | -$0.86 | -$0.73 | 15.12% | $0.00 | — | $0.00 | — | 05/04/2023 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.69 | -$0.80 | -$0.92 | -15.00% | $0.00 | — | $0.00 | — | 02/27/2023 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.79 | -$0.79 | -$0.87 | -10.13% | $0.00 | — | $0.00 | — | 11/03/2022 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.55 | -$0.68 | -$0.83 | -22.06% | $0.00 | — | $0.00 | — | 08/08/2022 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.65 | -$0.71 | -$0.67 | 5.63% | $0.00 | — | $0.00 | — | 05/05/2022 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$1.08 | -$0.76 | -$0.69 | 9.21% | $0.00 | — | $0.00 | — | 02/24/2022 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.53 | -$0.58 | -$0.79 | -36.21% | $0.00 | — | $0.00 | — | 11/03/2021 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.45 | -$0.65 | -$0.55 | 15.38% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.45 | -$0.71 | -$0.65 | 8.45% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.39 | -$0.52 | -$1.08 | -107.69% | $0.00 | — | $0.00 | — | 02/25/2021 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.38 | -$0.46 | -$0.53 | -15.22% | $0.00 | — | $0.00 | — | 11/04/2020 | Get Alert |
| RCKT | Rocket Pharmaceuticals | -$0.38 | -$0.51 | -$0.45 | 11.76% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
Rocket Pharmaceuticals (RCKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $-0.56 | $-0.58 | 3.45 % |
| Q4 | 2025-02-27 | $-0.62 | $-0.72 | 13.9 % |
| Q3 | 2024-11-07 | $-0.71 | $-0.76 | 6.58 % |
| Q2 | 2024-08-05 | $-0.74 | $-0.72 | -2.78 % |
Rocket Pharmaceuticals (RCKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $0 | $800.00K | -100.0 % |
| Q4 | 2025-02-27 | $0 | $31.30K | -100.0 % |
| Q3 | 2024-11-07 | $0 | $700.00K | -100.0 % |
FAQ
When is Rocket Pharmaceuticals (NASDAQ:RCKT) reporting earnings?
Rocket Pharmaceuticals (RCKT) is scheduled to report earnings on August 4, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Rocket Pharmaceuticals (NASDAQ:RCKT)?
The Actual EPS was $-0.56, which beat the estimate of $-0.58.
What were Rocket Pharmaceuticals’s (NASDAQ:RCKT) revenues?
The Actual Revenue was $0K, which missed the estimate of $800K.
Browse earnings estimates, EPS, and revenue on all stocks.
